Is Etoricoxib safe while breastfeeding?
Here is what LactMed, the Drugs and Lactation Database published by the U.S. National Institute of Child Health and Human Development (NICHD), reports about Etoricoxib. The text below is quoted from that source — it is not our own verdict.
Summary of use during breastfeeding
Etoricoxib is not approved for marketing in the United States by the U.S. Food and Drug Administration but is available in other countries. No information is available on the use of etoricoxib during breastfeeding. Because it is 92% protein bound, the amounts in milk are likely to be very low. Some guidelines recommend avoiding etoricoxib because of a lack of data during breastfeeding.[1] An alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Effects on the breastfed infant
Relevant published information was not found as of the revision date.
Effects on milk supply
Relevant published information was not found as of the revision date.
Levels in milk
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Alternatives LactMed lists
“No published information” means the studies do not exist yet — not that Etoricoxib is known to be harmful, and not that it is known to be safe. Your prescriber or pharmacist can weigh your baby's age and whether a better-studied alternative would do the same job. Worth asking before stopping a medicine you need.
Source: Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development (NICHD), via NCBI Bookshelf, record “Etoricoxib” (etoricoxib). LactMed on NCBI Bookshelf. LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Educational summary of an authoritative source — not medical advice. Never start, stop, or change a medicine while breastfeeding without confirming with your doctor.